Potential indicator for the early detection of dementias

August 7, 2018, University of Basel
Credit: CC0 Public Domain

Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions after disturbances of the mitochondria, the cellular power plants, as neuropathologists write in the journal Cell Reports.

The normal functioning of human cells is based on the coordinated interaction of different cellular organelles. In many cases, impaired communication between these organelles will lead to the activation of a response to ensure the survival of affected cells. A research group was able to demonstrate this in detail for brain neurons. The group is headed by Prof. Dr. Stephan Frank from the Institute of Medical Genetics and Pathology at the University of Basel and University Hospital of Basel; the universities of Cambridge (UK) and Padua (Italy) were also involved.

The neuropathologists were able to show that impairments on the level of also affect neighboring organelles, such as the so-called endoplasmic reticulum. A consecutively activated stress reaction leads to the release of fibroblast growth factor 21 (FGF21) by nerve cells with disturbed mitochondria. The Basel researchers further observed that the same substance is also induced in various models of neurodegenerative disorders, where it can be detected prior to .

Therapies against chronic cell stress?

As chronic cell stress is an important factor in the development of , FGF21 could potentially be suitable as a biomarker for the pre-symptomatic detection of diseases such as Alzheimer's or Parkinson's. However, as FGF21 can also be produced by other tissues and organs, such as adipose tissue and the liver, further rigorous testing will be required in this regard. The availability of a robust biomarker would represent an important advance in the development of novel approaches targeting chronic cell stress to provide neuroprotection.

Annual health care expenses for dementia-related neurodegenerative disorders amount to approx. CHF 7 billion in Switzerland, with demographic estimates projecting a 1.7 increase in the prevalence of these disorders over the next ten years due to increasing life expectancy.

Explore further: Stress gene regulates brain cell power and connections in rodents

More information: Cell Reports (2018). DOI: 10.1016/j.celrep.2018.07.023

Related Stories

Stress gene regulates brain cell power and connections in rodents

January 2, 2018
A gene activated by stress adjusts energy output and synapse number of prefrontal cortex neurons, finds a study of male mice and rats published in JNeurosci. The results were validated in brain tissue of deceased patients ...

A new puzzle piece to control the aging and age-related diseases

May 10, 2018
A basic discovery of how the cellular functions are connected to control aging is presented in the journal Cell Metabolism. The study shows that an increasingly deteriorating communication between the cells' organelles is ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.